Company Information 75 2 Annual Report 2017  |  EKF Diagnostics Holdings plc
for the year ended 31 December 2017  EKF Diagnostics Holdings plc | Annual Report 2017  15
Finance Director and Chief Operating Officer  EKF Diagnostics Holdings plc | Annual Report 2017  17
financial statements of EKF Diagnostics Holdings plc for the year ended 31 December 2017.
The Directors who held office during the year and as at the date of signing the financial statements 
During the year the principal activities of the Group and Company were the development, 
for the year ended 31 December 2017 18 Annual Report 2017  |  EKF Diagnostics Holdings plc
The directors are responsible for preparing the Annual Report and the financial statements in 
Company law requires the directors to prepare financial statements for each financial year.
that law the directors have prepared the group financial statements in accordance with International 
presume that the group and parent company will continue in business.
and explain the group and parent company’s transactions and disclose with reasonable accuracy   EKF Diagnostics Holdings plc | Annual Report 2017  19
at any time the financial position of the group and parent company and enable them to ensure that 
the financial statements comply with the Companies Act 2006 and, as regards the group financial 
The directors are also responsible for safeguarding the assets of the group and parent company and 
• the parent company financial statements, which have been prepared in accordance with 
• the group financial statements, which have been prepared in accordance with IFRSs as 
• the Chairman’s Statement, Chief Executive’s Review and Finance Director’s Review include a 
and of any Company in the Group.
Finance Director and Chief Operating Officer 20 Annual Report 2017  |  EKF Diagnostics Holdings plc
for the year ended 31 December 2017  EKF Diagnostics Holdings plc | Annual Report 2017  21
With effect from the financial year to 31 December 2016, the Group became subject to the 
Finance Director and COO  EKF Diagnostics Holdings plc | Annual Report 2017  23
report sets out the Group policy on Directors’ remuneration, including emoluments, benefits and 
for the year ended 31 December 2017 24 Annual Report 2017  |  EKF Diagnostics Holdings plc
Directors’ interests in the share capital of the Company are disclosed in the Directors’ Report on 
Finance Director and COO  EKF Diagnostics Holdings plc | Annual Report 2017  25
In our opinion, EKF Diagnostics Holdings plc’s group financial statements and parent company 
• give a true and fair view of the state of the group’s and of the parent company’s affairs as at 
31 December 2017 and of the group’s profit and the group’s and the parent company’s cash 
We have audited the financial statements, included within the Annual Report (the “Annual 
• Overall group materiality: £415,000, based on 1% of revenue.
• Share-based payment transactions (Group and parent).
an opinion on the financial statements as a whole, taking into account the structure of the group 
Group financial statements Parent company financial statements
during our audit above £21,000 (group audit) and £19,000 (parent company audit) as well as 
• the directors have not disclosed in the financial statements any identified material 
In preparing the financial statements, the directors are responsible for assessing the group’s and 
• the parent company financial statements are not in agreement with the accounting records 
for the year ended 31 December 2017 32 Annual Report 2017  |  EKF Diagnostics Holdings plc
for the year ended 31 December 2017 34 Annual Report 2017  |  EKF Diagnostics Holdings plc
Consolidated Statement of Changes in Equity  EKF Diagnostics Holdings plc | Annual Report 2017  35
The consolidated financial statements of EKF Diagnostics Holdings plc have been prepared in 
The following standards have been adopted by the Group for the first time for the financial year 
statements of the group or parent company, except the following, set out below:
financial assets: amortised cost; fair value through other comprehensive income; and fair 
The Directors believe that the Company and the Group have adequate resources to continue in 
the fair value of the Group’s share of the identifiable net assets acquired is recorded as goodwill.
Items included in the financial statements of each of the Group’s entities are measured using 
Goodwill represents the excess of the cost of an acquisition over the fair value of the Group’s share 
Available-for-sale assets are non-derivatives that are either designated in this category or not   EKF Diagnostics Holdings plc | Annual Report 2017  41
Borrowing costs are expensed in the consolidated Group income statement under the heading 
The Group operates a number of equity-settled, share-based compensation plans, under which the 
share-based payments are measured at fair value at each reporting date and are expensed over the 
Revenue from the sale of services is recognised when a Group Company has 
Dividend distributions to the Company’s shareholders are recognised as a liability in the Group’s 
Other income includes grant income and R & D tax credits passed through income where this is  44 Annual Report 2017  |  EKF Diagnostics Holdings plc
Group does not speculate in foreign currencies and no operating Company is permitted to take 
Credit risk is managed on a Group basis, except for credit risk relating to accounts receivable 
The Group has no Level 1, 2 or 3 classified financial assets as at 31 December 2017 (2016: none).
Directors and the monthly management reports are used by the Group to make strategic decisions 
Net finance costs 422 676 52 Annual Report 2017  |  EKF Diagnostics Holdings plc
Basic profit/(loss) per share 0.59 pence (0.00) pence   EKF Diagnostics Holdings plc | Annual Report 2017  53
The Company holds capitalised development costs with a cost and net value of £1,876,000 (2016: 
Company Shares in Group undertakings
the Group and Company, with the exception of deferred equity consideration totalling £1,062,000 
Group and Company
Group and Company Number of Shares
Group and Company
The Group also leases various office equipment and assets under non-cancellable operating lease 
Group Company
Company Secretary 74 Annual Report 2017  |  EKF Diagnostics Holdings plc